{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T13:38:55Z","timestamp":1788183535836,"version":"build-2803163510"},"reference-count":78,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004374","name":"Medtronic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004374","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007497","name":"Biosense Webster","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007497","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","elsevier.es","revespcardiol.org","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition)"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.rec.2024.02.008","type":"journal-article","created":{"date-parts":[[2024,2,29]],"date-time":"2024-02-29T06:46:54Z","timestamp":1709189214000},"page":"690-696","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Novel stroke prevention strategies following catheter ablation for atrial fibrillation"],"prefix":"10.1016","volume":"77","author":[{"given":"Wern Yew","family":"Ding","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Calvert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory Y H","family":"Lip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhiraj","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rec.2024.02.008_bib0395","doi-asserted-by":"crossref","first-page":"i4482","DOI":"10.1136\/bmj.i4482","article-title":"Atrial fibrillation and risks of cardiovascular disease, renal disease, and death: systematic review and meta-analysis","author":"Odutayo","year":"2016","journal-title":"BMJ."},{"key":"10.1016\/j.rec.2024.02.008_bib0400","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/nrcardio.2017.153","article-title":"The ABC pathway: an integrated approach to improve AF management","volume":"14","author":"Lip","year":"2017","journal-title":"Nat Rev Cardiol."},{"key":"10.1016\/j.rec.2024.02.008_bib0405","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1055\/a-1515-9630","article-title":"Adherence to the \u2018Atrial Fibrillation Better Care\u2019 Pathway in Patients with Atrial Fibrillation: Impact on Clinical Outcomes\u2014A Systematic Review and Meta-Analysis of 285,000 Patients","volume":"122","author":"Romiti","year":"2022","journal-title":"Thromb Haemost."},{"key":"10.1016\/j.rec.2024.02.008_bib0410","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ejim.2022.11.004","article-title":"Impact of ABC (Atrial Fibrillation Better Care) pathway adherence in high-risk subgroups with atrial fibrillation: A report from the ESC-EHRA EORP-AF long-term general registry","volume":"107","author":"Ding","year":"2023","journal-title":"Eur J Intern Med."},{"key":"10.1016\/j.rec.2024.02.008_bib0415","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.recesp.2021.07.012","article-title":"Epidemiology of atrial fibrillation-related ischemic stroke and its association with DOAC uptake in Spain: first national population-based study 2005 to 2018","volume":"75","author":"D\u00edaz-Guzm\u00e1n","year":"2022","journal-title":"Rev Esp Cardiol."},{"key":"10.1016\/j.rec.2024.02.008_bib0420","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.recesp.2021.02.007","article-title":"Trade-off between the effects of embolic versus bleeding events on mortality in elderly patients with atrial fibrillation","volume":"75","author":"Raposeiras-Roub\u00edn","year":"2022","journal-title":"Rev Esp Cardiol."},{"key":"10.1016\/j.rec.2024.02.008_bib0425","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1093\/europace\/euaa299","article-title":"Catheter ablation: the \u2018Pym Particles\u2019 of atrial fibrillation?","volume":"23","author":"Ding","year":"2021","journal-title":"Europace."},{"key":"10.1016\/j.rec.2024.02.008_bib0430","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","article-title":"2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the Europe","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur Heart J."},{"key":"10.1016\/j.rec.2024.02.008_bib0435","doi-asserted-by":"crossref","first-page":"e275","DOI":"10.1016\/j.hrthm.2017.05.012","article-title":"2017 HRS\/EHRA\/ECAS\/APHRS\/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation","volume":"14","author":"Calkins","year":"2017","journal-title":"Heart Rhythm."},{"key":"10.1016\/j.rec.2024.02.008_bib0440","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.chest.2018.07.040","article-title":"Antithrombotic Therapy for Atrial Fibrillation","volume":"154","author":"Lip","year":"2018","journal-title":"Chest."},{"key":"10.1016\/j.rec.2024.02.008_bib0445","doi-asserted-by":"crossref","first-page":"e033357","DOI":"10.1136\/bmjopen-2019-033357","article-title":"Has the introduction of direct oral anticoagulants (DOACs) in England increased emergency admissions for bleeding conditions? A longitudinal ecological study","volume":"10","author":"Alfirevic","year":"2020","journal-title":"BMJ Open."},{"key":"10.1016\/j.rec.2024.02.008_bib0450","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1055\/s-0042-1750385","article-title":"Assessment and Mitigation of Bleeding Risk in Atrial Fibrillation and Venous Thromboembolism: Executive Summary of a European and Asia-Pacific Expert Consensus Paper","volume":"122","author":"Gorog","year":"2022","journal-title":"Thromb Haemost."},{"key":"10.1016\/j.rec.2024.02.008_bib0455","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1136\/heartjnl-2020-316977","article-title":"Atrial fibrillation and the prothrombotic state: revisiting Virchow's triad in 2020","volume":"106","author":"Ding","year":"2020","journal-title":"Heart."},{"key":"10.1016\/j.rec.2024.02.008_bib0460","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1093\/europace\/euq346","article-title":"A Study of blood soluble P-selectin, fibrinogen, and von Willebrand factor levels in idiopathic and lone atrial fibrillation","volume":"13","author":"Fu","year":"2011","journal-title":"Europace."},{"key":"10.1016\/j.rec.2024.02.008_bib0465","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0167-5273(00)00336-3","article-title":"Correlation between left atrial size, prothrombotic state and markers of endothelial dysfunction in patients with lone chronic nonrheumatic atrial fibrillation","volume":"75","author":"Mondillo","year":"2000","journal-title":"Int J Cardiol."},{"key":"10.1016\/j.rec.2024.02.008_bib0470","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.4022\/jafib.2297","article-title":"Paroxysmal Atrial Fibrillation: An Independent Risk Factor for Prothrombotic Conditions","volume":"13","author":"Negreva","year":"2020","journal-title":"J Atr Fibrillation."},{"key":"10.1016\/j.rec.2024.02.008_bib0475","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1177\/1076029616654262","article-title":"Decreased Activity of the Protein C Anticoagulant Pathway in the Early Hours of Paroxysmal Atrial Fibrillation","volume":"23","author":"Negreva","year":"2017","journal-title":"Clin Appl Thromb Hemost."},{"key":"10.1016\/j.rec.2024.02.008_bib0480","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijcard.2017.03.023","article-title":"Platelet reactivity and mean platelet volume as risk markers of thrombogenesis in atrial fibrillation","volume":"235","author":"Makowski","year":"2017","journal-title":"Int J Cardiol."},{"key":"10.1016\/j.rec.2024.02.008_bib0485","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s11239-017-1548-3","article-title":"Catheter ablation for AF improves global thrombotic profile and enhances fibrinolysis","volume":"44","author":"Niespialowska-Steuden","year":"2017","journal-title":"J Thromb Thrombolysis."},{"key":"10.1016\/j.rec.2024.02.008_bib0490","doi-asserted-by":"crossref","first-page":"e623","DOI":"10.1161\/CIR.0000000000000568","article-title":"Atrial Fibrillation Burden: Moving Beyond Atrial Fibrillation as a Binary Entity: A Scientific Statement From the American Heart Association","volume":"137","author":"Chen","year":"2018","journal-title":"Circulation."},{"key":"10.1016\/j.rec.2024.02.008_bib0495","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1055\/a-1541-3885","article-title":"Risk of Ischemic Stroke in Asymptomatic Atrial Fibrillation Incidentally Detected in Primary Care Compared with Other Clinical Presentations","volume":"122","author":"Wallenhorst","year":"2022","journal-title":"Thromb Haemost."},{"key":"10.1016\/j.rec.2024.02.008_bib0500","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1055\/a-1562-0747","article-title":"Screening for Atrial Fibrillation in Relation to Stroke and Mortality Risk","volume":"122","author":"Proietti","year":"2022","journal-title":"Thromb Haemost."},{"key":"10.1016\/j.rec.2024.02.008_bib0505","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1093\/eurheartj\/eht491","article-title":"Device-detected atrial fibrillation and risk for stroke: an analysis of >10,000 patients from the SOS AF project (Stroke preventiOn Strategies based on Atrial Fibrillation information from implanted devices)","volume":"35","author":"Boriani","year":"2014","journal-title":"Eur Heart J."},{"key":"10.1016\/j.rec.2024.02.008_bib0510","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1001\/jamacardio.2018.1176","article-title":"Association of Burden of Atrial Fibrillation With Risk of Ischemic Stroke in Adults With Paroxysmal Atrial Fibrillation","volume":"3","author":"Go","year":"2018","journal-title":"JAMA Cardiol."},{"key":"10.1016\/j.rec.2024.02.008_bib0515","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1056\/NEJMoa2303062","article-title":"Anticoagulation with Edoxaban in Patients with Atrial High-Rate Episodes","volume":"389","author":"Kirchhof","year":"2023","journal-title":"New Engl J Med."},{"key":"10.1016\/j.rec.2024.02.008_bib0520","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1056\/NEJMoa2310234","article-title":"Apixaban for Stroke Prevention in Subclinical Atrial Fibrillation","volume":"390","author":"Healey","year":"2024","journal-title":"N Engl J Med."},{"key":"10.1016\/j.rec.2024.02.008_bib0525","article-title":"Direct Oral Anticoagulants for Stroke Prevention in Patients with Device-Detected Atrial Fibrillation: A Study-Level Meta-Analysis of the NOAH-AFNET 6 and ARTESiA Trials","author":"McIntyre","year":"2023","journal-title":"Circulation."},{"key":"10.1016\/j.rec.2024.02.008_bib0530","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/jce.15308","article-title":"Bayesian network meta-analysis comparing cryoablation, radiofrequency ablation, and antiarrhythmic drugs as initial therapies for atrial fibrillation","volume":"33","author":"Elsayed","year":"2022","journal-title":"J Cardiovasc Electrophysiol."},{"key":"10.1016\/j.rec.2024.02.008_bib0535","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1093\/europace\/euab029","article-title":"Cryoballoon ablation vs. antiarrhythmic drugs: first-line therapy for patients with paroxysmal atrial fibrillation","volume":"23","author":"Kuniss","year":"2021","journal-title":"Europace."},{"key":"10.1016\/j.rec.2024.02.008_bib0540","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s10840-018-0349-8","article-title":"Catheter ablation versus medical therapy for patients with persistent atrial fibrillation: a systematic review and meta-analysis of evidence from randomized controlled trials","volume":"52","author":"Chen","year":"2018","journal-title":"J Interv Card Electrophysiol."},{"key":"10.1016\/j.rec.2024.02.008_bib0545","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1161\/CIRCEP.114.001759","article-title":"Efficacy of Catheter Ablation for Persistent Atrial Fibrillation","volume":"7","author":"Wynn","year":"2014","journal-title":"Circ Arrhythm Electrophysiol."},{"key":"10.1016\/j.rec.2024.02.008_bib0550","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1136\/heartjnl-2021-319496","article-title":"Catheter ablation as first-line treatment for paroxysmal atrial fibrillation: a systematic review and meta-analysis","volume":"107","author":"Imberti","year":"2021","journal-title":"Heart."},{"key":"10.1016\/j.rec.2024.02.008_bib0555","doi-asserted-by":"crossref","first-page":"68","DOI":"10.15420\/aer.2021.01","article-title":"Impact of the Pattern of Atrial Fibrillation on Stroke Risk and Mortality","volume":"10","author":"Botto","year":"2021","journal-title":"Arrhythm Electrophysiol Rev."},{"key":"10.1016\/j.rec.2024.02.008_bib0560","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.amjcard.2018.11.055","article-title":"Meta-analysis of Stroke and Bleeding Risk in Patients with Various Atrial Fibrillation Patterns Receiving Oral Anticoagulants","volume":"123","author":"Zhang","year":"2019","journal-title":"Am J Cardiol."},{"key":"10.1016\/j.rec.2024.02.008_bib0565","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1093\/europace\/euaa298","article-title":"Catheter ablation or medical therapy to delay progression of atrial fibrillation: the randomized controlled atrial fibrillation progression trial (ATTEST)","volume":"23","author":"Kuck","year":"2021","journal-title":"Europace."},{"key":"10.1016\/j.rec.2024.02.008_bib0570","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1056\/NEJMoa2212540","article-title":"Progression of Atrial Fibrillation after Cryoablation or Drug Therapy","volume":"388","author":"Andrade","year":"2023","journal-title":"New Engl J Med."},{"key":"10.1016\/j.rec.2024.02.008_bib0575","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1161\/CIRCEP.113.000495","article-title":"Progression of Atrial Fibrillation After a Failed Initial Ablation Procedure in Patients With Paroxysmal Atrial Fibrillation","volume":"6","author":"Pokushalov","year":"2013","journal-title":"Circ Arrhythm Electrophysiol."},{"key":"10.1016\/j.rec.2024.02.008_bib0580","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1093\/europace\/euaa235","article-title":"Atrial fibrillation and the risk of ischaemic strokes or intracranial haemorrhages: comparisons of the catheter ablation, medical therapy, and non-atrial fibrillation population","volume":"23","author":"Kim","year":"2021","journal-title":"Europace."},{"key":"10.1016\/j.rec.2024.02.008_bib0585","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1093\/eurheartj\/ehz085","article-title":"Atrial fibrillation ablation in practice: assessing CABANA generalizability","volume":"40","author":"Noseworthy","year":"2019","journal-title":"Eur Heart J."},{"key":"10.1016\/j.rec.2024.02.008_bib0590","first-page":"e9701","article-title":"Does Catheter Ablation Lower the Long-Term Risk of Stroke and Mortality in Patients with Atrial Fibrillation? A Concise Review of the Current State of Knowledge","volume":"12","author":"Ryad","year":"2020","journal-title":"Cureus."},{"key":"10.1016\/j.rec.2024.02.008_bib0595","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1055\/a-1807-0336","article-title":"Early Rhythm Control and the Risks of Ischemic Stroke, Heart Failure, Mortality, and Adverse Events When Performed Early (<3 Months): A Nationwide Cohort Study of Newly Diagnosed Patients with Atrial Fibrillation","volume":"122","author":"Chao","year":"2022","journal-title":"Thromb Haemost."},{"key":"10.1016\/j.rec.2024.02.008_bib0600","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ahj.2017.12.007","article-title":"The Optimal Anti-Coagulation for Enhanced-Risk Patients Post\u2013Catheter Ablation for Atrial Fibrillation (OCEAN) trial","volume":"197","author":"Verma","year":"2018","journal-title":"Am Heart J."},{"key":"10.1016\/j.rec.2024.02.008_bib0605","doi-asserted-by":"crossref","first-page":"f366","DOI":"10.1093\/europace\/eux297","article-title":"Outcomes of persistent and long-standing persistent atrial fibrillation ablation: a systematic review and meta-analysis","volume":"20","author":"Clarnette","year":"2018","journal-title":"Europace."},{"key":"10.1016\/j.rec.2024.02.008_bib0610","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1001\/jamainternmed.2013.1561","article-title":"Discerning the Incidence of Symptomatic and Asymptomatic Episodes of Atrial Fibrillation Before and After Catheter Ablation (DISCERN AF)","volume":"173","author":"Verma","year":"2013","journal-title":"JAMA Intern Med."},{"key":"10.1016\/j.rec.2024.02.008_bib0615","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1055\/s-0041-1739411","article-title":"2021 Focused Update Consensus Guidelines of the Asia Pacific Heart Rhythm Society on Stroke Prevention in Atrial Fibrillation: Executive Summary","volume":"122","author":"Chao","year":"2022","journal-title":"Thromb Haemost."},{"key":"10.1016\/j.rec.2024.02.008_bib0620","article-title":"Stroke and Bleeding Risk Assessments in Patients With Atrial Fibrillation: Concepts and Controversies","volume":"7","author":"Ding","year":"2020","journal-title":"Front Med (Lausanne)."},{"key":"10.1016\/j.rec.2024.02.008_bib0625","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus Warfarin in Patients with Atrial Fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"New Engl J Med."},{"key":"10.1016\/j.rec.2024.02.008_bib0630","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation","volume":"365","author":"Patel","year":"2011","journal-title":"New Engl J Med."},{"key":"10.1016\/j.rec.2024.02.008_bib0635","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1056\/NEJMoa1007432","article-title":"Apixaban in Patients with Atrial Fibrillation","volume":"364","author":"Connolly","year":"2011","journal-title":"New Engl J Med."},{"key":"10.1016\/j.rec.2024.02.008_bib0640","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1056\/NEJMoa1310907","article-title":"Edoxaban versus Warfarin in Patients with Atrial Fibrillation","volume":"369","author":"Giugliano","year":"2013","journal-title":"New Engl J Med."},{"key":"10.1016\/j.rec.2024.02.008_bib0645","doi-asserted-by":"crossref","first-page":"e002597","DOI":"10.1161\/JAHA.115.002597","article-title":"Patterns of Anticoagulation Use and Cardioembolic Risk After Catheter Ablation for Atrial Fibrillation","volume":"4","author":"Noseworthy","year":"2015","journal-title":"J Am Heart Assoc."},{"key":"10.1016\/j.rec.2024.02.008_bib0650","doi-asserted-by":"crossref","first-page":"e007612","DOI":"10.1161\/CIRCEP.119.007612","article-title":"Outcomes and Anticoagulation Use After Catheter Ablation for Atrial Fibrillation","volume":"12","author":"Freeman","year":"2019","journal-title":"Circ Arrhythm Electrophysiol."},{"key":"10.1016\/j.rec.2024.02.008_bib0655","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1253\/circj.CJ-19-0602","article-title":"Current Status and Clinical Outcomes of Oral Anticoagulant Discontinuation After Ablation for Atrial Fibrillation in Japan\u2014 Findings From the AF Frontier Ablation Registry \u2014","volume":"83","author":"Okumura","year":"2019","journal-title":"Circulation."},{"key":"10.1016\/j.rec.2024.02.008_bib0660","doi-asserted-by":"crossref","first-page":"e0253709","DOI":"10.1371\/journal.pone.0253709","article-title":"Discontinuation of oral anticoagulation therapy after successful atrial fibrillation ablation: A systematic review and meta-analysis of prospective studies","volume":"16","author":"Liu","year":"2021","journal-title":"PLoS One."},{"key":"10.1016\/j.rec.2024.02.008_bib0665","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/jce.13822","article-title":"Anticoagulation after catheter ablation of atrial fibrillation: An unnecessary evil? A systematic review and meta-analysis","volume":"30","author":"Proietti","year":"2019","journal-title":"J Cardiovasc Electrophysiol."},{"key":"10.1016\/j.rec.2024.02.008_bib0670","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1093\/europace\/euz235","article-title":"The safety of discontinuation of oral anticoagulation therapy after apparently successful atrial fibrillation ablation: a report from the Chinese Atrial Fibrillation Registry study","volume":"22","author":"Yang","year":"2020","journal-title":"Europace."},{"key":"10.1016\/j.rec.2024.02.008_bib0675","doi-asserted-by":"crossref","DOI":"10.1177\/10760296221118480","article-title":"Benefits and Risks Associated with Long-term Oral Anticoagulation after Successful Atrial Fibrillation Catheter Ablation: Systematic Review and Meta-analysis","volume":"28","author":"Maduray","year":"2022","journal-title":"Clin Appl Thromb Hemost."},{"key":"10.1016\/j.rec.2024.02.008_bib0680","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1111\/jce.14052","article-title":"Oral anticoagulation after catheter ablation of atrial fibrillation and the associated risk of thromboembolic events and intracranial hemorrhage: A systematic review and meta-analysis","volume":"30","author":"Romero","year":"2019","journal-title":"J Cardiovasc Electrophysiol."},{"key":"10.1016\/j.rec.2024.02.008_bib0685","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1111\/jce.15866","article-title":"\u201cPill-in-Pocket\u201d anticoagulation for stroke prevention in atrial fibrillation","volume":"34","author":"Peigh","year":"2023","journal-title":"J Cardiovasc Electrophysiol."},{"key":"10.1016\/j.rec.2024.02.008_bib0690","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.3390\/jcm11092428","article-title":"Cardiac Rhythm Monitoring Using Wearables for Clinical Guidance before and after Catheter Ablation","volume":"11","author":"Hillmann","year":"2022","journal-title":"J Clin Med."},{"key":"10.1016\/j.rec.2024.02.008_bib0695","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1056\/NEJMoa1901183","article-title":"Large-Scale Assessment of a Smartwatch to Identify Atrial Fibrillation","volume":"381","author":"Perez","year":"2019","journal-title":"New Engl J Med."},{"key":"10.1016\/j.rec.2024.02.008_bib0700","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1016\/j.jacc.2019.08.019","article-title":"Mobile Photoplethysmographic Technology to Detect Atrial Fibrillation","volume":"74","author":"Guo","year":"2019","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.rec.2024.02.008_bib0705","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1161\/CIRCULATIONAHA.122.060291","article-title":"Detection of Atrial Fibrillation in a Large Population Using Wearable Devices: The Fitbit Heart Study","volume":"146","author":"Lubitz","year":"2022","journal-title":"Circulation."},{"key":"10.1016\/j.rec.2024.02.008_bib0710","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1093\/europace\/euac038","article-title":"How to use digital devices to detect and manage arrhythmias: an EHRA practical guide","volume":"24","author":"Svennberg","year":"2022","journal-title":"Europace."},{"key":"10.1016\/j.rec.2024.02.008_bib0715","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1161\/CIRCULATIONAHA.113.007825","article-title":"Temporal Relationship Between Subclinical Atrial Fibrillation and Embolic Events","volume":"129","author":"Brambatti","year":"2014","journal-title":"Circulation."},{"key":"10.1016\/j.rec.2024.02.008_bib0720","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1161\/CIRCEP.114.003057","article-title":"Atrial Fibrillation Burden and Short-Term Risk of Stroke","volume":"8","author":"Turakhia","year":"2015","journal-title":"Circ Arrhythm Electrophysiol."},{"key":"10.1016\/j.rec.2024.02.008_bib0725","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1001\/jamacardio.2021.3702","article-title":"Temporal Association Between Episodes of Atrial Fibrillation and Risk of Ischemic Stroke","volume":"6","author":"Singer","year":"2021","journal-title":"JAMA Cardiol."},{"key":"10.1016\/j.rec.2024.02.008_bib0730","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1093\/eurheartj\/ehv115","article-title":"Randomized trial of atrial arrhythmia monitoring to guide anticoagulation in patients with implanted defibrillator and cardiac resynchronization devices","volume":"36","author":"Martin","year":"2015","journal-title":"Eur Heart J."},{"key":"10.1016\/j.rec.2024.02.008_bib0735","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/jce.12864","article-title":"Targeted Anticoagulation for Atrial Fibrillation Guided by Continuous Rhythm Assessment With an Insertable Cardiac Monitor: The Rhythm Evaluation for Anticoagulation With Continuous Monitoring (REACT.COM) Pilot Study","volume":"27","author":"Passman","year":"2016","journal-title":"J Cardiovasc Electrophysiol."},{"key":"10.1016\/j.rec.2024.02.008_bib0740","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1016\/j.hrthm.2018.06.027","volume":"15","author":"Waks","year":"2018","journal-title":"Heart Rhythm."},{"key":"10.1016\/j.rec.2024.02.008_bib0745","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1161\/CIRCEP.109.849638","article-title":"The Relationship Between Daily Atrial Tachyarrhythmia Burden From Implantable Device Diagnostics and Stroke Risk","volume":"2","author":"Glotzer","year":"2009","journal-title":"Circ Arrhythm Electrophysiol."},{"key":"10.1016\/j.rec.2024.02.008_bib0750","first-page":"443","article-title":"Atrial High-Rate Episodes Detected by Cardiac Implantable Electronic Devices: Dynamic Changes in Episodes and Predictors of Incident Atrial Fibrillation","volume":"11","author":"Imberti","year":"2022","journal-title":"Biology (Basel)."},{"key":"10.1016\/j.rec.2024.02.008_bib0755","doi-asserted-by":"crossref","DOI":"10.1016\/j.tcm.2023.11.003","article-title":"Concurrent percutaneous left atrial appendage occlusion and catheter ablation for atrial fibrillation: State-of-the-art review","author":"Mills","year":"2023","journal-title":"Trends Cardiovasc Med."},{"key":"10.1016\/j.rec.2024.02.008_bib0760","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.recesp.2023.06.005","article-title":"Single antiplatelet therapy after left atrial appendage closure in patients with AF: safety and effectiveness","volume":"77","author":"Llagostera-Mart\u00edn","year":"2024","journal-title":"Rev Esp Cardiol."},{"key":"10.1016\/j.rec.2024.02.008_bib0765","doi-asserted-by":"crossref","first-page":"674612","DOI":"10.3389\/fcvm.2021.674612","article-title":"Atrial Cardiomyopathy: An Emerging Cause of the Embolic Stroke of Undetermined Source","volume":"8","author":"Ning","year":"2021","journal-title":"Front Cardiovasc Med."},{"key":"10.1016\/j.rec.2024.02.008_bib0770","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1161\/STROKEAHA.117.020059","article-title":"Atrial Cardiopathy and the Risk of Ischemic Stroke in the CHS (Cardiovascular Health Study)","volume":"49","author":"Kamel","year":"2018","journal-title":"Stroke."},{"key":"10.1016\/j.rec.2024.02.008_bib0775","doi-asserted-by":"crossref","first-page":"e013227","DOI":"10.1161\/JAHA.119.013227","article-title":"Atrial Cardiopathy in the Absence of Atrial Fibrillation Increases Risk of Ischemic Stroke, Incident Atrial Fibrillation, and Mortality and Improves Stroke Risk Prediction","volume":"9","author":"Edwards","year":"2020","journal-title":"J Am Heart Assoc."},{"key":"10.1016\/j.rec.2024.02.008_bib0780","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1136\/heartjnl-2013-305303","article-title":"Prediction of stroke or TIA in patients without atrial fibrillation using CHADS2 and CHA2DS2-VASc scores","volume":"100","author":"Mitchell","year":"2014","journal-title":"Heart."}],"container-title":["Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1885585724000719?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1885585724000719?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,27]],"date-time":"2024-07-27T13:27:20Z","timestamp":1722086840000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1885585724000719"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":78,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S1885585724000719"],"URL":"https:\/\/doi.org\/10.1016\/j.rec.2024.02.008","relation":{},"ISSN":["1885-5857"],"issn-type":[{"value":"1885-5857","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel stroke prevention strategies following catheter ablation for atrial fibrillation","name":"articletitle","label":"Article Title"},{"value":"Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rec.2024.02.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.recesp.2024.02.008","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Sociedad Espa\u00f1ola de Cardiolog\u00eda. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}